CREDIT: CENTER FOR NANOSCALE MATERIALS, ARGONNE NATIONAL LABORATORY Alzheimer’s disease is the sixth leading cause of death in the United States, affecting one in 10 people over the age of 65. Scientists are engineering nanodevices to disrupt processes in the brain that lead to the disease. People who are affected by Alzheimer’s disease have a...
Researchers are developing potential treatment for chronic pain
Researchers from the University of Copenhagen have developed a new way to treat chronic pain which has been tested in mice. With a compound designed and developed by the researchers themselves, they can achieve complete pain relief. Between seven and ten percent of the world’s population suffers from chronic pain originating from nerves that have...
Temple scientists regenerate neurons in mice with spinal cord injury and optic nerve damage
New research by scientists at the Lewis Katz School of Medicine Temple University (LKSOM) shows, however, that gains in functional recovery from these injuries may be possible, thanks to a molecule known as Lin28, which regulates cell growth. In a study published online in the journal Molecular Therapy, the Temple researchers describe the ability of...
Novel method produces life-saving T cells from mesenchymal stromal cells
Durham, NC – A new study released today in STEM CELLS suggests for the first time that regulatory T-cells (Treg) induced by mesenchymal stromal cells can yield an abundant replacement for naturally occurring T-cells, which are vital in protecting the body from infection. Led by Rita I. Azevedo, Ph.D., at the Instituto de Medicina Molecular...
Older men with sarcopenia are more likely to develop diabetes over time
Older men with sarcopenia are more likely to develop diabetes over time New findings point to age-related muscle loss as a contributing factor to diabetes in the elderly THE ENDOCRINE SOCIETY PRINT E-MAIL WASHINGTON–Older men who have lower lean body mass as they age are more prone to developing diabetes, while similar findings were not...
Innovative approach offers option for treating upper tract urothelial cancer
Treatment of low-grade upper tract urothelial cancer usually involves radical surgery to remove the kidney and ureter, highlighting the need for improved treatments. An international team led by researchers at Baylor College of Medicine reports in the journal The Lancet Oncology that an innovative form of local chemotherapy using a mitomycin-containing reverse thermal gel offers...
Drug reduces the risk of child sexual abuse
Technology Org Science and technology news Drug reduces the risk of child sexual abuse Posted Today A drug that lowers levels of the male hormone testosterone in the body reduces the risk of men with pedophilic disorder sexually abusing children, a study from Karolinska Institutet published in the journal JAMA Psychiatry shows. About one in...
Certain diabetes drugs may protect against serious kidney problems
Use of sodium-glucose cotransporter 2 (SGLT2) inhibitors to treat type 2 diabetes may help to lower the risk of serious kidney problems, according to a Scandinavian study led by researchers at Karolinska Institutet. The findings, now published in the journal The BMJ, provide support for the use of SGLT2 inhibitors in a broad range of...
NANOPARTICLES ENTER LIVING CELLS TO GATHER CANCER CLUES
A new imaging technique sends nanoparticles into living cells to reveal important information about cell structure—including how tumor cells physically change as they form a tumor.A new imaging technique sends nanoparticles into living cells to reveal important information about cell structure—including how tumor cells physically change as they form a tumor.A new imaging technique sends...
ACE inhibitors appear to be safe and beneficial for COVID-19, say researchers
By Sally Robertson, B.Sc Researchers in India have conducted a meta-analysis investigating the effects of using angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) on outcomes among patients with COVID-19. They say their data suggest that continuing these treatments among this patient group is not only safe but significantly reduces the risk of severe...